Chenyi Liang
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 4
- Peptidase Inhibition and Analysis 2
- Pancreatic and Hepatic Oncology Research 1
-
- Phagocytosis and Immune Regulation 2
- Immunotherapy and Immune Responses 1
- Co-authors
- W. David McGuinn (1 shared paper)Rajeshwari Sridhara (1 shared paper)Gang Chen (1 shared paper)David E. Morse (1 shared paper)Martin H. Cohen (1 shared paper)Sophia Abraham (1 shared paper)Richard Pazdur (1 shared paper)Grant A. Williams (1 shared paper)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Research (2 papers)Molecular Pharmaceutics (1 paper)Clinical Cancer Research (1 paper)Nature Biomedical Engineering (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenyi Liang
8 papers receiving 532 citations
Peers
Comparison fields: 5 of 75
- Oncology 258
- Pulmonary and Respiratory Medicine 224
- Cancer Research 56
- Radiology, Nuclear Medicine and Imaging 70
- Genetics 25
Countries citing papers authored by Chenyi Liang
This map shows the geographic impact of Chenyi Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyi Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyi Liang more than expected).
Fields of papers citing papers by Chenyi Liang
This network shows the impact of papers produced by Chenyi Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyi Liang. The network helps show where Chenyi Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenyi Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 418 | |
| 2 | 2023 | 40 | |
| 3 | 2021 | 29 | |
| 4 | 2023 | 26 | |
| 5 | 2023 | 17 | |
| 6 | 2021 | 8 | |
| 7 | 2025 | 6 | |
| 8 | 2023 | 5 |
About Chenyi Liang
Chenyi Liang is a scholar working on Oncology, Immunology, Cancer Research, Organic Chemistry and Surgery, having authored 8 papers that have together received 549 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers), Phagocytosis and Immune Regulation (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Optical Imaging and Spectroscopy Techniques (1 paper), Immunotherapy and Immune Responses (1 paper), Quinazolinone synthesis and applications (1 paper) and Remote Sensing and LiDAR Applications (1 paper). The work is most often cited by research in Oncology (258 citations), Pulmonary and Respiratory Medicine (224 citations), Cancer Research (56 citations), Radiology, Nuclear Medicine and Imaging (70 citations) and Genetics (25 citations). Chenyi Liang has collaborated with scholars based in China and United States. Frequent co-authors include W. David McGuinn, Rajeshwari Sridhara, Gang Chen, David E. Morse, Martin H. Cohen, Sophia Abraham, Richard Pazdur, Grant A. Williams, Atiqur Rahman and Richard T. Lostritto. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Research, Molecular Pharmaceutics, Clinical Cancer Research and Nature Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.